Delivery Order SPE2DR25D2104-SPE2DR26F3SQK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,110.14 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of December 30, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $14,758.51 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,208.18 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $5,712.57 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,966.57 delivery order for Vivitrol 380 mg vial-diluents, with a completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $2,002.34 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with an ultimate completion date of July 15, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial with diluents. This contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use...
- The Defense Logistics Agency awarded a delivery order valued at $2,110.14 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of December 22, 2025, and represents a non-set-aside competitive award. Performance will occur at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency has awarded a delivery order valued at $40,167.61 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under a larger contract vehicle supporting the federal...
- The Defense Logistics Agency awarded a $2,087.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with an ultimate completion date of September 24, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the company's...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SQKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,110.14 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of January 2, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX), which serves as a global pharmaceutical support vehicle supplying military healthcare systems worldwide. Vivitrol, a medication used in opioid addiction treatment and management, supports the Department of Defense's medical supply chain requirements. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling specialized pharmaceutical procurement needs across multiple therapeutic domains for defense and veteran healthcare systems, positioning the company as a critical vendor for military medical supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/30/25 |